The Cambridge Life Sciences Careers Fair gives you the opportunity to meet all students and researchers across the university including undergraduates, MPhils, PhDs and postdocs. Attendees will be interested in learning more about the variety of roles available in the life science sector, from roles in Research & Development as well as a broad range of non-research career paths.
Diversity at Altos
Altos Labs has been named one of the Top 3 Biotech Companies and ranked for the second year on the Forbes 2026 Best Startups in America list. At Altos, exceptional scientists and industry leaders from around the world work together to advance a shared mission. Our intentional focus is on Belonging, so that all employees know that they are valued for their unique perspectives. We are all accountable for sustaining a diverse and inclusive environment.
What You Will Contribute To Altos
The recent cyberattack on Stryker, a leading medical technology manufacturer, serves as a stark reminder of the escalating risks posed by state-linked cyber threats to commercial organisations. Attributed to the Iran-linked hacktivist group Handala, the attack caused widespread disruption across 79 countries, wiping over 200,000 devices and compromising 50 terabytes of data. The attack underscores the urgent need for robust identity governance, network segmentation, and resilient backup strategies to mitigate the impact of such attacks.
The Company
When the science succeeds, the launch must too.
UK-founded BrandLaunchX launches on 12 May with a live online World Premiere event for biotech and pharma commercial leaders.
Cambridge entrepreneur Mark Boon has launched Aguila, a new insurance broker in Cambridge, to support founders at the forefront of the exploding life science and deeptech revolutions, unlocking potential for expansion across the UK, EU and US.
Having spent the last five years focussed on the US startup scene, Mark has turned his attention back to Cambridge, together with Co-Founder Luke Chesworth, identifying an unmet need for a deeper understanding by insurance advisers on the emerging risks in this hotbed of intellectual property, AI and compute power.
